Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Bite and Sting Medicated Relief Pads

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
July 7, 2017
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
July 7, 2017
Manufacturer
CVS
Registration number
part348
NDC root
69842-855
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You can use this medication for the temporary relief of pain and itching caused by minor cuts, scrapes, and burns. It is designed to help soothe discomfort and promote healing in these common skin injuries. If you experience any of these issues, this product may provide the relief you need.

Uses

If you’re dealing with minor cuts, scrapes, or burns, this medication can help provide temporary relief from pain and itching. It’s designed to soothe discomfort and make your healing process a bit easier. Just remember, it’s meant for minor injuries, so if you have more serious wounds, you should consult a healthcare professional.

Dosage and Administration

If you or your child is 2 years of age or older, you can apply the medication directly to the affected area of the skin. It’s important to do this no more than 3 to 4 times a day to ensure safety and effectiveness.

For children under 2 years old, it’s best to consult with a doctor before using this medication. They can provide guidance on the appropriate treatment for younger children. Always follow these instructions carefully to achieve the best results.

What to Avoid

It's important to use this medication safely and effectively. To ensure your well-being, keep it out of reach of children. If your condition worsens or if symptoms persist for more than 7 days, or if they improve and then return within a few days, stop using the medication and consult your doctor. Additionally, avoid contact with your eyes and always use the medication exactly as directed.

By following these guidelines, you can help prevent any potential issues and ensure the best results from your treatment.

Side Effects

It's important to be aware that this product is flammable, so you should avoid using it while smoking or near any heat or flame. If your condition worsens, or if your symptoms last more than 7 days or improve only to return within a few days, you should stop using the product and consult a doctor.

Warnings and Precautions

It's important to be aware that this product is flammable, so you should avoid using it while smoking or near any heat or flame. Always keep it out of reach of children, and if a child accidentally ingests it, seek professional help or contact a Poison Control Center right away.

You should stop using this product and call your doctor if your condition worsens, if your symptoms last more than 7 days, or if your symptoms improve and then come back within a few days. Taking these precautions can help ensure your safety and well-being.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information provided about overdose symptoms or effects, general signs of an overdose can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these symptoms or feel concerned, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get professional assistance if you think you or someone else may have taken too much of a medication. Remember, timely intervention can be crucial.

Pregnancy Use

When it comes to using this medication during pregnancy, specific information about its safety and recommended use is not provided. It's important to consult with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They can give you personalized advice based on your health needs and the latest medical guidelines.

Always prioritize open communication with your doctor about any medications you are taking or considering during pregnancy. This ensures that you receive the best care for both you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations regarding the use of this product while nursing. This means that it is not expected to affect your milk production or pose any risk to your infant through breast milk. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

When using this medication for children, it's important to follow specific guidelines. For children aged 2 years and older, you can apply the medication to the affected area up to 3 to 4 times a day. However, if your child is under 2 years old, you should consult a doctor before use. Always keep the medication out of reach of children to prevent accidental ingestion. If your child accidentally swallows any of the medication, seek professional help or contact a Poison Control Center right away.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you or how your liver health should be considered when taking it.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help you understand how to manage your liver health while considering any medications you may need.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best performance of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to maintain its integrity. Once you open the container, be sure to discard any remaining contents after use to ensure safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If the patient is under 2 years old, it's important to consult a doctor before use. There are no additional details available regarding laboratory tests, abuse potential, or postmarketing experiences related to this medication.

FAQ

What is the purpose of this drug?

This drug is for the temporary relief of pain and itching associated with minor cuts, scrapes, and minor burns.

How should I use this drug?

For adults and children 2 years of age and older, apply to the affected area no more than 3 to 4 times daily. For children under 2 years of age, ask a doctor.

What should I do if my condition worsens?

Stop use and ask a doctor if your condition worsens or if symptoms last more than 7 days or clear up and occur again within a few days.

Are there any warnings I should be aware of?

Yes, this product is flammable; do not use it while smoking or near heat or flame.

What precautions should I take when using this drug?

Keep this drug out of reach of children. In case of accidental ingestion, seek professional help or contact a Poison Control Center immediately.

How should I store this drug?

Store at room temperature, protect from light, and keep the container tightly closed. Discard after opening.

Is this drug safe to use during pregnancy or while nursing?

There are no specific warnings or considerations mentioned regarding the use of this product during pregnancy or lactation.

Packaging Info

Below are the non-prescription pack sizes of Bite and Sting Medicated Relief Pads (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Medicated Relief Pads.
Details

Drug Information (PDF)

This file contains official product information for Bite and Sting Medicated Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No specific description details are available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor cuts, scrapes, and minor burns. It is intended for use in patients experiencing discomfort from these specific skin injuries.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area, not exceeding 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to keep the product out of reach of children. If the condition worsens, or if symptoms persist for more than 7 days or recur after clearing up, discontinue use and consult a healthcare professional. Additionally, avoid contact with eyes and use the product only as directed.

Warnings and Precautions

Flammable substances should be handled with extreme caution. It is imperative to avoid using this product while smoking or in proximity to heat or open flames to prevent fire hazards.

To ensure safety, this product must be kept out of the reach of children. In the event of accidental ingestion, it is crucial to seek professional medical assistance or contact a Poison Control Center immediately.

Patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. These steps are essential to ensure appropriate management and to prevent potential complications.

No specific emergency medical help instructions or laboratory tests have been provided; however, healthcare professionals should remain vigilant and exercise clinical judgment in the management of any adverse events associated with the use of this product.

Side Effects

Patients should be aware of the potential for serious adverse reactions associated with the use of this product. It is flammable; therefore, it should not be used while smoking or near heat or flame.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. These guidelines are essential to ensure patient safety and to mitigate any risks associated with the use of the product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Bite and Sting Medicated Relief Pads (benzocaine - 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Medicated Relief Pads.
Details

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is advised to consult a doctor prior to use.

It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or contact a Poison Control Center.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal impacts associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or considerations regarding the use of this product by lactating mothers. Additionally, there are no known concerns related to the potential for excretion in breast milk or risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that particular substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek professional medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, patients should also stop use and seek medical advice.

It is important to remind patients to avoid contact with their eyes while using this product. Furthermore, patients should be counseled to use the product only as directed to ensure safety and efficacy.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a doctor before use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Bite and Sting Medicated Relief Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Bite and Sting Medicated Relief Pads, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.